Account

New to ADSS? Open an
account now to get started.

OR

Already have an account?

Add funds to your ADSS account

Account

New to ADSS? Open an
account now to get started.

Add funds to your ADSS account

Trends & Analysis
News

Week Ahead Preview: 27th of January

News

Crude oil dips after Trump proposes price cut

News

What are the chances of a CAD comeback?

News

P&G’s shares spike on upbeat earnings

News

USD/CAD price hinges on Trump’s decision

News

Netflix streams strong Q4 results, stock jumps 14%

Trends & Analysis
News

Week Ahead Preview: 27th of January

News

Crude oil dips after Trump proposes price cut

News

What are the chances of a CAD comeback?

News

P&G’s shares spike on upbeat earnings

News

USD/CAD price hinges on Trump’s decision

News

Netflix streams strong Q4 results, stock jumps 14%

10x Genomics (TXG) – Share price chart, background, and sentiment

Widgets supplied in partnership with Acuity. Pricing and sentiment does not represent ADSS data or market view.

10x Genomics is an American biotechnology company that provides gene sequencing to researchers.

10x Genomics Share Price Today

Widgets supplied in partnership with Acuity. Pricing and sentiment does not represent ADSS data or market view.

10x Genomics was founded by Serge Saxonov, Ben Hindson and Kevin Ness in 2012, and provides gene sequencing to commercial and public research clients. Since the company’s 2019 IPO, major acquisitions have given the 10x Genomics business lines in epigenetic research and spatial genomics. The product mix of 10x Genomics includes Visium, that allows researchers to analyse frozen or fixed tissue samples and is also the largest overall contributor to revenue, and Chromium, which offers single cell analysis.

Why trade equities with ADSS?

Competitive prices

Enjoy highly competitive CFD pricing across global markets.

Every market’s waiting

Trade CFDs globally and locally across asset classes.

Enhanced trading experience

Benefit from using our comprehensive and customisable trading platform.

Related equities

Platform

Your new trading adventure starts today

Discover our intuitive, next-generation trading platform


Site by Pink Green
© ADSS 2025


Investing in CFDs involves a high degree of risk that you will lose your money due to the use of leverage, particularly in fast moving markets, where a relatively small movement in the price can lead to a proportionately larger movement in the value of your investment. This can result in loses that exceed the funds in your account. You should consider whether you understand how CFDs work and you should seek independent advice if necessary.

ADS Securities LLC – S.P.C (“ADSS”) is authorised and regulated by the Securities and Commodities Authority (“SCA”) in the United Arab Emirates under First Category: Dealing in Securities and Fifth category: Arrangement and advice (Introduction). ADSS is a Limited Liability Company – Sole Proprietorship Company incorporated under United Arab Emirates law. The company is registered with the Department of Economic Development of Abu Dhabi (No. 1190047) and has its principal place of business at 8th Floor, CI Tower, Corniche Road, P.O. Box 93894, Abu Dhabi, United Arab Emirates.

The information presented is not directed at residents of any particular country outside the United Arab Emirates and is not intended for distribution to, or use by, any person in any country where the distribution or use is contrary to local law or regulation.

ADSS is an execution only service provider and does not provide advice. ADSS may publish general market commentary from time to time. Where it does, the material published does not constitute advice, or a solicitation, or a recommendation to a transaction in any financial instrument. ADSS accepts no responsibility for any use of the content presented and any consequences of that use. No representation or warranty is given as to the completeness of this information. Anyone acting on the information provided does so at their own risk.